| 摘要 |
<p>The present invention includes a method of reducing or inhibiting the kinase activity of normal and mutated FLT3 in a cell or a subject, and the use of such compound for preventing or treating cell proliferative disorder(s) in a subject related to using a compound of the present invention: (see above formula) or pharmaceutically acceptable salt thereof.</p> |
